311 related articles for article (PubMed ID: 19959201)
1. Phosphodiesterase type V inhibitors: Occurrence and fate in wastewater and sewage sludge.
Nieto A; Peschka M; Borrull F; Pocurull E; Marcé RM; Knepper TP
Water Res; 2010 Mar; 44(5):1607-15. PubMed ID: 19959201
[TBL] [Abstract][Full Text] [Related]
2. Serial mixed-mode cation- and anion-exchange solid-phase extraction for separation of basic, neutral and acidic pharmaceuticals in wastewater and analysis by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.
Lavén M; Alsberg T; Yu Y; Adolfsson-Erici M; Sun H
J Chromatogr A; 2009 Jan; 1216(1):49-62. PubMed ID: 19054521
[TBL] [Abstract][Full Text] [Related]
3. In silico prediction of novel phosphodiesterase type-5 inhibitors derived from Sildenafil, Vardenafil and Tadalafil.
Antunes JE; Freitas MP; da Cunha EF; Ramalho TC; Rittner R
Bioorg Med Chem; 2008 Aug; 16(16):7599-606. PubMed ID: 18656371
[TBL] [Abstract][Full Text] [Related]
4. Multiresidue trace analysis of sulfonamide antibiotics and their metabolites in soils and sewage sludge by pressurized liquid extraction followed by liquid chromatography-electrospray-quadrupole linear ion trap mass spectrometry.
García-Galán MJ; Díaz-Cruz S; Barceló D
J Chromatogr A; 2013 Feb; 1275():32-40. PubMed ID: 23312557
[TBL] [Abstract][Full Text] [Related]
5. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients.
Weeks JL; Zoraghi R; Beasley A; Sekhar KR; Francis SH; Corbin JD
Int J Impot Res; 2005; 17(1):5-9. PubMed ID: 15538396
[TBL] [Abstract][Full Text] [Related]
6. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
Uckert S; Sormes M; Kedia G; Scheller F; Knapp WH; Jonas U; Stief CG
Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202
[TBL] [Abstract][Full Text] [Related]
7. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
[TBL] [Abstract][Full Text] [Related]
8. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
[TBL] [Abstract][Full Text] [Related]
9. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
10. Comparison of TCPP concentrations in sludge and wastewater in a typical German sewage treatment plant-comparison of sewage sludge from 20 plants.
Bester K
J Environ Monit; 2005 May; 7(5):509-13. PubMed ID: 15877174
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous ultra-high-pressure liquid chromatography-tandem mass spectrometry determination of amphetamine and amphetamine-like stimulants, cocaine and its metabolites, and a cannabis metabolite in surface water and urban wastewater.
Bijlsma L; Sancho JV; Pitarch E; Ibáñez M; Hernández F
J Chromatogr A; 2009 Apr; 1216(15):3078-89. PubMed ID: 19201418
[TBL] [Abstract][Full Text] [Related]
12. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
Radjenović J; Petrović M; Barceló D
Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
[TBL] [Abstract][Full Text] [Related]
13. Tadalafil and vardenafil.
Neumeyer K; Kirkpatrick P
Nat Rev Drug Discov; 2004 Apr; 3(4):295-6. PubMed ID: 15124623
[No Abstract] [Full Text] [Related]
14. Detection and validated quantification of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, tadalafil, and 2 of their metabolites in human blood plasma by LC-MS/MS--application to forensic and therapeutic drug monitoring cases.
Rust KY; Wilkens H; Kaiser R; Bregel D; Wilske J; Kraemer T
Ther Drug Monit; 2012 Dec; 34(6):729-35. PubMed ID: 23128911
[TBL] [Abstract][Full Text] [Related]
15. Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cyclic guanosine monophosphate and inhibitors.
Zoraghi R; Francis SH; Corbin JD
Biochemistry; 2007 Nov; 46(47):13554-63. PubMed ID: 17979301
[TBL] [Abstract][Full Text] [Related]
16. Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5--sildenafil, tadalafil, and vardenafil.
Dustan Sarazan R; Crumb WJ; Beasley CM; Emmick JT; Ferguson KM; Strnat CA; Sausen PJ
Eur J Pharmacol; 2004 Oct; 502(3):163-7. PubMed ID: 15476742
[TBL] [Abstract][Full Text] [Related]
17. Determination of fluoroquinolone antibiotics in wastewater effluents by liquid chromatography-mass spectrometry and fluorescence detection.
Nakata H; Kannan K; Jones PD; Giesy JP
Chemosphere; 2005 Feb; 58(6):759-66. PubMed ID: 15621189
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum.
Lau LC; Adaikan PG
Eur J Pharmacol; 2006 Jul; 541(3):184-90. PubMed ID: 16777087
[TBL] [Abstract][Full Text] [Related]
19. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast.
Gómez MJ; Martínez Bueno MJ; Lacorte S; Fernández-Alba AR; Agüera A
Chemosphere; 2007 Jan; 66(6):993-1002. PubMed ID: 16962638
[TBL] [Abstract][Full Text] [Related]
20. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
Briganti A; Salonia A; Gallina A; Saccà A; Montorsi P; Rigatti P; Montorsi F
Nat Clin Pract Urol; 2005 May; 2(5):239-47. PubMed ID: 16474835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
